ADIPOA - Clinical Study

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

Autologous adipose derived stem cells administrated for intra-articular use

Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues.

BIOLOGICAL

Autologous adipose derived stem cells administrated for intra-articular use

Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. The first patient will be followed during 12 weeks before inclusion of the second patient.

Trial Locations (2)

34295

UH Montpellier, Montpellier

97074

Orthopädische Klinik, Würzburg

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT01585857 - ADIPOA - Clinical Study | Biotech Hunter | Biotech Hunter